Medicon Hellas S.A. operates in the diagnostics industry that offers instruments, tests, and procedures to clinical and research labs in Greece and internationally. It manufactures, imports, and provides diagnostic and point-of-care test systems, molecular diagnostics, laboratory automation, work flow improvement, and software solutions and services to state and private hospitals and laboratories. The company also produces and exports clinical chemistry, hematology and immunochemistry reagents. In addition, it offers analyzers, reagents, controls, calibrators, and consumables to biochemistry hematology, immunology, molecular, microbiology, and blood gases sectors; laboratory equipment, such as centrifugal, vortex/shakers, adjustable volume pipettes, and air purifiers; and cosmetics. Further, the company provides service/refurbishment, diagnostic labs, and informatics/software services. Medicon Hellas S.A. was incorporated in 1988 and is headquartered in Gerakas, Greece.
Metrics to compare | MEDr | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipMEDrPeersSector | |
|---|---|---|---|---|
P/E Ratio | 6.5x | 15.1x | −0.6x | |
PEG Ratio | 0.05 | 0.07 | 0.00 | |
Price/Book | 0.6x | 2.2x | 2.6x | |
Price / LTM Sales | 0.6x | 2.2x | 3.4x | |
Upside (Analyst Target) | - | 42.3% | 43.4% | |
Fair Value Upside | Unlock | 17.8% | 6.3% | Unlock |